Masayuki Miyata

Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka et al. · Annals of the Rheumatic Diseases · 2016 · 109 citations · Full text

Athymic Nude Rats Develop Severe Pulmonary Hypertension following Monocrotaline Administration

Masayuki Miyata, Fumitaka Sakuma, Masayuki Itô et al. · International Archives of Allergy and Immunology · 2000 · 49 citations

Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study)

Yuko Kaneko, Masaru Kato, Yoshiya Tanaka et al. · Annals of the Rheumatic Diseases · 2018 · 48 citations · Full text

Protective Effect of Beraprost Sodium, a Stable Prostacyclin Analogue, in Development of Monocrotaline-Induced Pulmonary Hypertension

Masayuki Miyata, Yuji Ueno, Hideharu Sekine et al. · Journal of Cardiovascular Pharmacology · 1996 · 44 citations

Inflammation, Beraprost Sodium, Hypertension +15

Effect of a Serotonin Receptor Antagonist on Interleukin-6-Induced Pulmonary Hypertension in Rats

Masayuki Miyata, Masayuki Itô, Tomomi Sasajima et al. · CHEST Journal · 2001 · 43 citations

Inflammation, Hypertension, Pulmonary Arterial Hypertension +10